BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2982278)

  • 1. Inhibition of sarcolemmal Na+-K+-ATPase by palmitoyl carnitine: potentiation by propranolol.
    Kramer JH; Weglicki WB
    Am J Physiol; 1985 Jan; 248(1 Pt 2):H75-81. PubMed ID: 2982278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of palmitoyl carnitine on Na+, K+-ATPase and adenylate cyclase activity of canine myocardial sarcolemma.
    Abe M; Yamazaki N; Suzuki Y; Kobayashi A; Ohta H
    J Mol Cell Cardiol; 1984 Mar; 16(3):239-45. PubMed ID: 6325716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac sarcolemmal Na+-K+-ATPase: combined effects of propranolol and arachidonyl CoA.
    Kramer JH; Owens K; Weglicki WB
    Am J Physiol; 1983 May; 244(5):H738-42. PubMed ID: 6303134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of palmitoyl carnitine and LPC on cardiac sarcolemmal Na+-K+-ATPase.
    Pitts BJ; Okhuysen CH
    Am J Physiol; 1984 Nov; 247(5 Pt 2):H840-6. PubMed ID: 6093598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fatty acid intermediates on Na+-K+-ATPase activity of cardiac sarcolemma.
    Owens K; Kennett FF; Weglicki WB
    Am J Physiol; 1982 Mar; 242(3):H456-61. PubMed ID: 6278956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perturbations of sarcolemmal and microsomal enzymes by amphiphilic lipids and drugs.
    Weglicki WB; Kramer JH; Kennett FF; Knauer TE; Owens K
    Adv Myocardiol; 1985; 6():127-36. PubMed ID: 2986257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of lipid intermediates on Ca2+ and Na+ permeability and (Na+ + K+)-ATPase of cardiac sarcolemma. A possible role in myocardial ischemia.
    Lamers JM; Stinis HT; Montfoort A; Hülsmann WC
    Biochim Biophys Acta; 1984 Jul; 774(1):127-37. PubMed ID: 6329291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of palmitoyl carnitine with calcium antagonists in myocytes.
    Patmore L; Duncan GP; Spedding M
    Br J Pharmacol; 1989 Jun; 97(2):443-50. PubMed ID: 2474346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of free radical-induced lipid peroxidative injury to sarcolemmal membranes by lipid amphiphiles.
    Mak IT; Kramer JH; Weglicki WB
    J Biol Chem; 1986 Jan; 261(3):1153-7. PubMed ID: 3003057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous palmitoyl carnitine and membrane damage in rat hearts.
    Busselen P; Sercu D; Verdonck F
    J Mol Cell Cardiol; 1988 Oct; 20(10):905-16. PubMed ID: 3216401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of palmitylcarnitine on ouabain binding to Na, K-ATPase.
    Adams RJ; Pitts BJ; Woods JM; Gende OA; Wallick ET; Schwartz A
    J Mol Cell Cardiol; 1979 Oct; 11(10):941-59. PubMed ID: 230355
    [No Abstract]   [Full Text] [Related]  

  • 12. Palmitoyl carnitine increases intracellular calcium in adult rat cardiomyocytes.
    Netticadan T; Yu L; Dhalla NS; Panagia V
    J Mol Cell Cardiol; 1999 Jul; 31(7):1357-67. PubMed ID: 10403753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of palmitoyl CoA of EDTA- and Mg2+-ATPase of heavy meromyosin from rabbit skeletal muscle.
    Fujiwara A; Fujisaki H; Asai H; Yasumasu I
    J Biochem; 1981 Sep; 90(3):757-63. PubMed ID: 6118360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of some L-carnitine derivatives on heart membrane ATPases.
    Dhalla NS; Kolár F; Shah KR; Ferrari R
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():25-30. PubMed ID: 1851632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of propionyl L-carnitine on sarcolemmal changes in congestive heart failure due to myocardial infarction.
    Sethi R; Dhalla KS; Ganguly PK; Ferrari R; Dhalla NS
    Cardiovasc Res; 1999 Jun; 42(3):607-15. PubMed ID: 10533600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [M-cholinergic regulation of Na+,K+-ATPase activity of vesicular preparations of sarcolemma from the myocardium and intestinal smooth muscles].
    Danilenko MP; Smagulova ZSh; Turmukhambetova VK; Omarova RD; Esyrev OV
    Ukr Biokhim Zh (1978); 1988; 60(1):55-60. PubMed ID: 2834846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of acetylcholine on the Na+,K+-ATPase activity of different preparations of myocardial sarcolemma].
    Danilenko MP; Kum EA; Omarova RD; Esyrev OV
    Vopr Med Khim; 1983; 29(1):29-33. PubMed ID: 6301155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of a GTP-binding protein in coupling of a muscarinic cholinergic receptor and Na,K-ATPase in myocardial sarcolemma].
    Turmukhambetova VK; Danilenko MP; Panchenko MP; Ritov VB; Esyrev OV; Tkachuk VA
    Biokhimiia; 1992 Feb; 57(2):163-73. PubMed ID: 1326337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcolemmal Na(+)-K(+)-ATPase: inactivation by neutrophil-derived free radicals and oxidants.
    Kukreja RC; Weaver AB; Hess ML
    Am J Physiol; 1990 Nov; 259(5 Pt 2):H1330-6. PubMed ID: 2173423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of sarcolemma ATPases by some membrane-stabilizing drugs.
    Røed A; Brodal B
    Acta Pharmacol Toxicol (Copenh); 1981 Jan; 48(1):65-8. PubMed ID: 6261527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.